AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell ...

The batteries will be recyclable, in keeping with the Embleme’s philosophy – half of the concept’s materials are recycled and the carbon footprint of its components reduced by 70 per cent. This is an ...

Researchers, including those from the Indian Institute of Technology-Bombay and Tata Memorial Hospital, Mumbai, said in low ...

The EC has granted expanded approval to BMS' Breyanzi, to treat adults with relapsed or refractory follicular lymphoma (FL).

An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

The fuel gauge showed just a tiny amount of hydrogen in the vehicle’s tank, and someone on the sales staff at Roseville ...

Electric cars have soared in popularity in the wake of high gasoline prices. While improvements in vehicle battery technology ...

My survival is based on research. With limited NIH funding, I fear that my life, and the lives of others, will be left ...

Hydrogen-powered vehicles are the new kids on the block and they come with some advantages and disadvantages when compared to ...

EC approves BMY's Breyanzi for relapsed or refractory FL, based on Phase 2 study showing high response rates & sustained ...

During a Case-Based Roundtable® event, Ryan W. Jacobs, MD, discussed a patient who received 2 prior lines of therapy for ...